When did RESMED INC (RMD) report earnings last quarter?
RESMED INC (RMD) last reported earnings on 1/29/2026.
NYSE:RMD • US7611521078
Past quarterly earnings results for RESMED INC (RMD), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 2.81 | 2.75 | 2.15% | 15.64% | 1.423B | 1.41B | 0.91% | 10.98% |
| Q1 2026 | 2.55 | 2.58 | -1.16% | 15.91% | 1.336B | 1.344B | -0.63% | 9.07% |
| Q4 2025 | 2.55 | 2.51 | 1.74% | 22.60% | 1.348B | 1.338B | 0.75% | 10.20% |
| Q3 2025 | 2.37 | 2.38 | -0.57% | 11.27% | 1.292B | 1.299B | -0.56% | 7.92% |
| Q2 2025 | 2.43 | 2.34 | 3.93% | 29.26% | 1.282B | 1.28B | 0.16% | 10.26% |
| Q1 2025 | 2.20 | 2.06 | 6.87% | 34.15% | 1.225B | 1.192B | 2.73% | 11.08% |
| Q4 2024 | 2.08 | 2.09 | -0.37% | 30.00% | 1.223B | 1.229B | -0.47% | 9.01% |
| Q3 2024 | 2.13 | 1.93 | 10.24% | 26.79% | 1.197B | 1.179B | 1.53% | 7.17% |
| Q2 2024 | 1.88 | 1.81 | 3.67% | 13.25% | 1.163B | 1.158B | 0.41% | 12.48% |
| Q1 2024 | 1.64 | 1.63 | 0.42% | 8.61% | 1.102B | 1.109B | -0.60% | 16.00% |
| Q4 2023 | 1.60 | 1.71 | -6.31% | 7.38% | 1.122B | 1.152B | -2.60% | 22.66% |
| Q3 2023 | 1.68 | 1.60 | 4.83% | 27.27% | 1.117B | 1.057B | 5.67% | 29.20% |
| Q2 2023 | 1.66 | 1.63 | 1.59% | 12.93% | 1.034B | 1.011B | 2.25% | 15.52% |
| Q1 2023 | 1.51 | 1.53 | -1.43% | - | 950.294M | 953.52M | -0.34% | 5.12% |
| Q4 2022 | 1.49 | 1.47 | 1.64% | 10.37% | 914.737M | 922.1M | -0.80% | 4.41% |
| Q3 2022 | 1.32 | 1.44 | -8.07% | 1.54% | 864.5M | 906.01M | -4.58% | 12.45% |
| Q2 2022 | 1.47 | 1.54 | -4.25% | 4.26% | 894.874M | 944.61M | -5.27% | 11.86% |
| Q1 2022 | 1.51 | 1.37 | 10.03% | 18.90% | 904.015M | 869.5M | 3.97% | 20.23% |
| Q4 2021 | 1.35 | 1.32 | 2.62% | 1.50% | 876.103M | 804.28M | 8.93% | 13.74% |
| Q3 2021 | 1.30 | 1.28 | 1.45% | 0.78% | 768.8M | 801.1M | -4.03% | -0.09% |
| Q2 2021 | 1.41 | 1.28 | 9.82% | 16.53% | 800M | 794.14M | 0.74% | 8.67% |
| Q1 2021 | 1.27 | 1.04 | 22.38% | 36.56% | 751.9M | 717.84M | 4.74% | 10.39% |
| Q4 2020 | 1.33 | 1.09 | 21.51% | - | 770.3M | 754.37M | 2.11% | - |
| Q3 2020 | 1.29 | 1.06 | 22.22% | - | 769.5M | 729.74M | 5.45% | - |
| Q2 2020 | 1.21 | 1.03 | 16.95% | - | 736.2M | 737.77M | -0.21% | - |
| Q1 2020 | 0.93 | 0.88 | 5.72% | - | 681.1M | 667.27M | 2.07% | - |
Notes
RESMED INC (RMD) last reported earnings on 1/29/2026.
RESMED INC (RMD) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, RESMED INC (RMD) has beaten EPS estimates in 2 out of 4 releases.